| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $770K | +53.1% | +92.5% |
| R&D Expense | $13.5M | +10.1% | +29.0% |
| SG&A Expense | $9.2M | +66.7% | +1971.5% |
| Operating Income | -$30.0M | -444.3% | -6664.9% |
| Pre-tax Income | -$269.9M | -137.4% | -1310.0% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$269.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $146.2M | — | — |
| Accounts Receivable | $706K | — | — |
| Current Assets | $151.8M | +5268.2% | — |
| Total Assets | $177.8M | -68.3% | -67.4% |
| Current Liabilities | $34.7M | +185.0% | +5942.2% |
| Long-term Debt | $11.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$70.2M | — | — |
| Capital Expenditures | $11.9M | — | — |
| Investing Cash Flow | -$11.9M | — | — |
| Financing Cash Flow | $211.6M | — | — |
| Free Cash Flow | -$82.1M | — | — |
| — |
| -3975.7% |
| EPS (Basic) | -$3.89 | -105.8% | -1078.8% |
| EPS (Diluted) | -$3.89 | -105.8% | -1078.8% |
| +121.7% |
| +121.7% |
| Total Liabilities | $174.2M | +545.0% | +654.8% |
| Stockholders' Equity | -$219.5M | -811.8% | -919.2% |